Latest event summaries
Event summaries combining transcripts, slides, and related documents. Updated as new events are published.
- Skincare revenue surged 40.4% YoY, offsetting color cosmetics decline, but net loss widened.YSG
Q2 2026 - Recurring, high-margin enzyme sales drive scalable growth across diversified biotech markets.AZT
Pareto Securities' 17th Annual Healthcare Conference presentation - Omega acquisition drives turnkey expansion, new markets, and over 130% EBITDA CAGR.SEI
Acquisition presentation - Major launches in AI, sustainability, and gaming mark 50 years of barrier-breaking innovation.2353
IFA 2026 - Leviathan’s expansion and strong contracts drive growth, cash flow, and regional energy leadership.NWMD
Status update - All-share merger forms a global gaming leader with €2bn EBITDA, €115M synergies, and €4B returns.CIRSA
M&A announcement - All-share merger forms a €2B EBITDA gaming leader, targeting €115M synergies and €4B returns.LTMC
M&A announcement - Revenue up 8.3% and profit before tax up 5.1%, boosted by Pinago acquisition and higher output.AEP
H1 2026 - Adjusted operating profit up 37% to £18.5m, margin at 8.1%, and FY2026 outlook upgraded.TTG
H1 2026 - Record revenue and profit growth, upgraded guidance, and enhanced shareholder returns.CRN
H1 2026 - Sales up 4.8% with Foods leading, CRG profitable, and strategic reset amid macro headwinds.WHL
H2 2026 - Net profit up 3% to CHF 82.9m, revenue up 6.5%, equity at CHF 2.8bn, and strong non-life growth.VAHN
H1 2026 - Strong 1H 2026 growth with 10% normalized revenue and 27% EBITDA increase, led by renewables and acquisitions.PE
Q2 2026 - Revenue and profit declined sharply, but liquidity and digital investments remained strong.603833
Q2 2026 - Record sales and profits driven by ICT demand; outlook expects normalization post-special demand.8057
Q4 2026 - Revenue down 28% and losses persist, but restructuring and new contracts support recovery.TPGR
Q1 2027